skinny.

Latest / Lung Cancer Considered

Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance

In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib. Guest: Dr. Yasushi Goto from National Cancer Center, Japan in Tokyo Guest: Dr. Rachel Sanborn, the Earle A. Chiles Research Institute of the Providence Cancer Institute in Portland, Oregon

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.